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ABSTRACT
The etiology of hypertension, especially in pregnancy, is various and complex, involving both 
genetic and psychological factors. The aim of this study was to investigate the association be-
tween depression and hypertensive disorders in pregnancy. Its original contribution is to broadly 
address these types of hypertensive disorders. We conducted an integrative literature review 
and identified relevant studies from four databases, including MEDLINE, LILACS, SciELO and 
EMBASE. Qualitative and original studies in English, Spanish and Portuguese (Brazilian) pub-
lished between the years of 2005-2016 were included. Studies were selected by titles, abstracts 
and full texts, and its quality was evaluated by three researchers independently. Data showed that 
depression was associated to hypertensive disorders in pregnancy. Women with severe depres-
sive symptoms have higher risk to develop preeclampsia. The use of antidepressants also showed 
a large association to the hypertensive disorders in pregnancy. Conclusion: Current evidence 
indicates association between depression and hypertensive disorders in pregnancy. Physical care 
and mental health care of women is essential for a physiological and safe pregnancy.
KEYWORDS: hypertension, hypertension, pregnancy-induced hypertension, preeclampsia, 
depressive disorder, review.
RESUMEN
La etiología de la hipertensión, especialmente en el embarazo, es variada y compleja, involucran-
do factores genéticos y psicológicos. El objetivo de este estudio fue investigar la asociación entre 
la depresión y los trastornos hipertensivos en el embarazo. Su contribución original es el enfoque 
ampliado sobre estos tipos de trastornos hipertensivos. Realizamos una revisión bibliográfica in-
tegradora y identificamos estudios relevantes de cuatro bases de datos, que incluyen MEDLINE, 
LILACS, SciELO y EMBASE. Se incluyeron estudios cualitativos y originales en inglés, español 
y portugués (brasileño) publicados entre los años 2005-2016. Los estudios fueron seleccionados 
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por títulos, resúmenes y textos completos, y su calidad fue evaluada por tres investigadores de 
forma independiente. Los datos mostraron que la depresión estaba asociada a trastornos hiper-
tensivos en el embarazo. Las mujeres con síntomas depresivos graves tienen un mayor riesgo de 
desarrollar preeclampsia. El uso de antidepresivos también mostró una gran asociación con los 
trastornos hipertensivos en el embarazo. Conclusión: la evidencia actual indica asociación entre 
la depresión y los trastornos hipertensivos en el embarazo. El cuidado físico y el cuidado de la 
salud mental de las mujeres es esencial para una gestación fisiológica y segura.
PALABRAS CLAVE: hipertensión, hipertensión inducida en el embarazo, preeclampsia, tras-
torno depresivo, revisión por expertos.
INTRODUCTION
Pregnancy is considered one of the most important moments in a woman’s life. As a physiological 
phenomenon, the World Health Organization (WHO) defines gestation as a natural manifestation that 
triggers physiological, social and emotional changes [38]. Moreover, it is a time that provides sev-
eral physical and psychological transformations, preparing the pregnant woman for the baby’s birth. 
These alterations are such that some imbalances can occur, leading to the development of diseases.
Gestational hypertension is one of the most common cause of maternal morbidity and mortal-
ity [37]. It has been estimated that around 5-10 % of pregnant women will develop this disorder 
[30]. Pregnancy-induced hypertension has classically been classified as: chronic hypertension, pre-
eclampsia, eclampsia, preeclampsia superimposed on chronic hypertension and gestational hyperten-
sion without proteinuria (National High Blood Pressure Education Program Working Group on High 
Blood Pressure in Pregnancy 2000, [21]), being preeclampsia/eclampsia the most substantial effect 
on maternal and newborn health [27]. 
Regarding mental health, depression is one of the most prevalent complications during pregnancy 
[3, 10, 40]. It is defined as a clinical syndrome, with a multifactorial etiology (Diagnostic and statisti-
cal manual of mental disorders, 2013). The magnitude of such a problem is so great that WHO recog-
nizes depression as one of the major causes of morbidity and disability among young adults. Studies 
estimate that depression affects around 16 % of pregnant women [40]. The effects of this condition 
are numerous, since depression can affect the pregnant woman’s self-care and, consequently, cause 
problems to the newborn. 
Both hypertension and depression place women in greater need of care, since these conditions 
can lead to important dysfunctions in the body. Furthermore, the association between depression and 
hypertension is an important factor that should be evaluated during pregnancy. Of note, studies about 
psychological factors, such as depression and/or depressive symptoms associated to the risk of ges-
tational hypertension, have increased in the last years [30, 20]. However, this relation is still unclear.
The aim of this study was to search for evidence available in the literature related to depression 
and hypertensive disorders in pregnancy to answer the question: Is there any association between 
depression and hypertensive disorders? This review attempts to clarify if the intensity of depressive 
symptoms is related to a higher prevalence of hypertensive disorders and whether the use of antide-
pressants is related to this outcome or not.
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MATERIALS AND METHODS
The present research was conducted through an integrative literature review on the topic of depres-
sion and hypertension during pregnancy. This methodology allows a better understanding of issues 
already addressed by previous research. Moreover, it indicates which aspects need to be investigated 
in further studies [15]. 
This review considered the following steps: definition of the research question; selection of the 
inclusion and exclusion criteria of the studies; selection of databases and descriptors for the search; 
studies analysis; results interpretation and presentation of the review. The search for studies was con-
ducted on December 2018.
The databases consulted were: Medical Literature Analysis and Retrieval System Online (MED-
LINE), Literature in the Health Sciences in Latin America and the Caribbean (LILACS), Scientific 
Electronic Library Online (SciELO) and EMBASE.
For the search, descriptors were used related to depression and gestational hypertension, according 
to the Health Sciences Descriptors (DECS) and the Medical Subject Headings (MeSH). Only English, 
Spanish and Portuguese (Brazilian) clinical studies were included, published between the years of 
2005 and 2016.
The exclusion criteria considered were review articles, hypotheses, validation studies of scales, 
editorials and conference abstracts.
After the search, articles were assessed first by the title, followed by summary and careful reading 
of the full text. Data collection instrument used for analysis of the results was based on the article 
identification: Author/year/country; main characteristics of participants and main results.
RESULTS
Of the 397 different clinical studies conducted in women regarding depression and hypertension 
in pregnancy, 16 were included in the final analysis (Flow Chart 1).
Of the 381 studies that were excluded, 41 were review, 11 were in languages other than English, 
Spanish or Portuguese (Brazilian), one was a hypothesis study and the others were not related to the 
aim of this review.
The final sample of studies included in this research is presented in Table 1. 
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Flow Chart 1: Selection of studies included in the review.
Table 1. Studies included in integrative review
Author / year / country
Main characteristics 
of participants Study design Main results
Rouleau CR, et al.
2016.
Canada.
n = 287;
MA: 31.5;
GA: 
First evaluation: 14.9;
Second evaluation: 32.4.
Prospective 
longitudinal 
study.
In early pregnancy, women without gestational 
hypertension showed higher mean of depressive 
symptoms (5.7) than women with gestational 
hypertension (5.5). However, in late pregnancy 
women with gestational hypertension showed 
higher means (6.5 x 5.3)
Yedid Sion M, et al.
2016.
Israel.
n = 256312;
MA: 
Depression: 32.05;
No depression: 28.56;
GA:
Depression: 37.99;
No depression: 39.02.
Retrospec-
tive cohort 
study.
There was no significant difference between 
depressed and non-depressed women regarding 
preeclampsia incidence.
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Author / year / country
Main characteristics 
of participants Study design Main results
Franco RC, et al.
2015.
Brazil.
n = 105;
MA: 24; 
GA: third trimester.
Cross-sec-
tional study.
Depression is the risk factor for the occurrence of 
gestational arterial hypertension (OR 8.69).
Lutsiv O, et al.
2015.
Canada.
n = 70605 women;
50.3% were overweight/
obese;
MA: 30.1.
GA: >20.
Retrospec-
tive cohort 
study.
Normal weight (Body Mass Index - BMI, 18.5-
24.9kg/m2):
2.2 % depressed women had gestational hyperten-
sion and 1.5 % presented preeclampsia;
Overweight/obese (BMI ⩾25 kg/m2):
5.5 % depressed women had gestational hyperten-
sion and 3.1 % presented preeclampsia.
Avalos LA, et al.
2015.
USA.
n = 21589;
Electronic medical records of 
pregnant Kaiser Permanente 
Northern California mem-
bers.
MA: Not informed. 
GA: all pregnancy.
Retro-
spective 
population-
based cohort 
study.
Women who took antidepressant medications had 
increased risk of preeclampsia, compared to women 
with untreated depression or no depression.
Thombre MK, et al.
2015.
USA.
n = 1371;
MA: 28.7.
GA: 16-27.
Retrospec-
tive subco-
hort study.
Women’s lifetime history of depression symptoms 
was associated with a 2.3-fold higher risk of pre-
eclampsia.
Winkel S, et al.
2015.
Germany.
n = 283
25.8% were overweight;
MA: 28.2
GA: >12.
Prospective 
longitudinal 
study.
Women with comorbid anxiety and depressive 
disorder had a higher blood pressure (systolic: 
linear regression coefficient [β]= 3.0, 95 % confi-
dence interval [CI]=0.2–5.7; diastolic, β=2.3, 95 % 
CI=0.1–4.4).
Overweight (BMI ⩾25 kg/m2):
Women with overweight had significantly higher 
systolic and diastolic blood pressure compared to 
women with normal or underweight (crude: β = 6.3 
and β = 4.5; adjusted: β = 6.2 and β = 4.6).
No significant associations of overweight with anx-
iety liability and depression liability were apparent 
(linear regression: all p > 0.05; results on request).
Palmsten K, et al. 
2013.
USA.
n = 100942;
MA: 25.2.
GA: Not informed.
Retrospec-
tive cohort 
study.
The risk of preeclampsia was 5.4 % among women 
with depression and no antidepressant exposure. 
Compared with these women, the risk for pre-
eclampsia was higher among those receiving some 
antidepressants.
Katon WJ, et al.
2012.
USA.
n = 2398; 
MA: 30.5; 
GA: 23.3.
Prospective 
study.
Women with preexisting hypertension had higher 
risk of depression (OR=1.55) compared to women 
without hypertension. No differences were seen 
in risk of depression in women with pregnancy-
induced hypertension or preeclampsia/eclampsia 
compared to those without hypertension.
Palmsten K, et al.
2012.
Canada.
n = 69448;
MA: 31.
GA: >10.
Retrospec-
tive cohort 
study.
The risk of preeclampsia in depressed women not 
treated with antidepressants (2.4 %) was similar to 
that in women without depression (2.3 %). The use 
of antidepressants was associated with a higher risk 
of preeclampsia.
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Author / year / country
Main characteristics 
of participants Study design Main results
De Vera MA, Bérard A. 
2012.
Canada.
n = 13376;
1216 women with pregnancy-
induced hypertension and 
with no history of hyperten-
sion before pregnancy;
10 controls for each case;
MA: 27.3;
GA: 36.3.
Case-control.
The use of antidepressants during pregnancy had 
1.5-fold increased risk of pregnancy-induced 
hypertension.
Kharaghani R, et al.
2012.
Iran.
n = 312;
156 women with preeclamp-
sia and 156 women without 
any history of preeclampsia.
MA: 28.4;
GA: 35.7.
Case-control.
Women with mild depression had a 1.8-fold in-
creased risk for preeclampsia while moderate to se-
vere depression had a 2.5-fold higher risk compared 
to no depression women.
Bansil P, et al.
2010.
USA.
n = 32156438;
244939 women with depres-
sion diagnosis;
MA: 29.5;
GA: all pregnancy.
Retrospec-
tive cohort 
study.
Women with depression had a 1.5-fold higher risk 
for Preeclampsia/hypertension compared to women 
without depression.
Toh S, Mitchell AA, et al.
2009.
USA.
n = 5731 
MA: 32. 
GA: all pregnancy.
Retrospec-
tive cohort.
Gestational hypertension was present in 9.0 % of 
the women who were not treated with selective 
serotonin reuptake inhibitors (SSRIs) and 19.1 % of 
the women who were treated with SSRIs. Pre-
eclampsia occurred in 2.4 % of women who were 
not treated with SSRIs, 3.7 % in women who were 
exposed to SSRIs only during the first trimester, 
and 15.2 % in women who continued SSRI treat-
ment beyond the first trimester.
Vollebregt KC, et al.
2008.
The Netherlands.
n = 3679 nulliparous women;
MA: 29.9;
GA: all pregnancy.
Prospective 
community-
based cohort 
study.
The incidence of pre-eclampsia and gestational 
hypertension was 3.5 and 4.4 %. Depression had no 
effect on the incidence of pre-eclampsia or gesta-
tional hypertension.
Qiu C, et al.
2007.
Peru.
n = 676
339 preeclamptic women and 
337 normotensive controls.
MA: 26.2;
GA: all pregnancy.
Case-control.
Women with moderate and severe depression had a 
2.3-fold and a 3.2-fold increased risk of preeclamp-
sia, respectively, compared with non-depressed 
women.
MA=Maternal age (years); Gestational age (weeks).
Most studies were a retrospective cohort study. Case-control studies typically involved depres-
sive women who were compared to non-depressive women. One cross-sectional and four prospective 
community-based cohort studies were identified. 
Regarding publication year, most studies are recent. Publication year was concentrated from 2012 
ahead. 
In the 16 studies, a total of 32,703,552 women were analyzed, predominantly from North America 
- USA and Canada. Only two studies were from Europe, two were from Latin America and two other 
141Association between depression and hypertensive disorders during pregnancy: an integrative review
NEREIS 11 [Marzo 2019], 135-145, ISSN: 1888-8550
from Asia. The average age of participants was 25.21 years old. Gestational age most analyzed was 
third trimester.
In general, depression was associated to gestational hypertension, especially preeclampsia. De-
pression severity also contributed to increase the risk of hypertensive disorders in pregnancy, accord-
ing to authors.
Some studies explored the association between the use of antidepressants and the risk of gestation-
al hypertension and preeclampsia [1, 5, 19, 18]. According to that, women who take antidepressants 
have a 1.5-fold increased risk of pregnancy-induced hypertension [5]. 
Two studies also evaluate Body Mass Index (BMI). A study showed that depressed women who 
are also overweight or obese have a higher risk of gestational hypertension and preeclampsia [35]. 
However, another study found no significant association between overweight and depression suscep-
tibility, but showed higher blood pressure in overweight women [41].
Only two studies presented no significant association between depression and hypertensive disor-
ders in pregnancy [35, 41]. 
DISCUSSION
By conducting this review, we found that the association between depression and the risk of ges-
tational hypertension was high. In general, women with depressive symptoms were more likely to 
develop a hypertensive disorder. Especially, moderate and severe depression were around two times 
more associated with this outcome. Such associations can be explained by the woman’s lifestyle, 
neither based on healthy lifestyle habits [28], changes in the immune system, nor changes in the auto-
nomic nervous system and the hypothalamic-pituitary-adrenal axis [25] nor the increase in the release 
of pro-inflammatory markers [16]. 
Corroborating our findings, a recent meta-analysis also showed the association between depres-
sions with a moderately increased risk of preeclampsia [11]. Of note, our integrative review included 
not only preeclampsia as an outcome, but also the others hypertensive disorders in pregnancy. How-
ever, most studies rather focus on preeclampsia comprehension given its high rate of complications 
for pregnant women and the fetus.
On the other hand, a prospective community-based cohort study from 2008 with nulliparous wom-
en and a singleton pregnancy did not find any significant difference between having or not depression 
and incidence of hypertensive disorders [35]. These data are consistent with the main analyses from a 
systematic review and meta-analysis conducted in 2010 [9]. It should also be noted that most studies 
included in this integrative review were more recent, from years 2015 and 2016. Only one study did 
not find association between depressive symptoms and preeclampsia diagnosis and it is from Israel 
[41]. Additionally, it is important to consider cultural differences when we are thinking about psycho-
logical symptoms. Western and Eastern women can view the fact of being depressed, for example, in 
different ways. In our society, based on capitalist models, women are required to follow patterns that 
are not always easy to reach. Consequently, this can lead to important psychological changes such as 
the manifestation of more intense depressive symptoms; even because social pressure has an impor-
tant role in human behavior, especially regarding psychological symptoms [33]. Moreover, during 
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pregnancy, a period of great transformation in a woman’s life, this fact can intensify even more, caus-
ing other pathologies, like the alteration of the arterial pressure. 
Regarding antidepressants use, some studies also showed association with a higher risk of hy-
pertensive disorders in pregnancy. According to a recent systematic review, some antidepressants, 
especially selective serotonin reuptake inhibitors (SSRIs) and venlafaxine, have been associated to 
a higher risk of pregnancy complications, including preeclampsia [17]. It is important to consider 
that antidepressants use may be related to higher severity of depressive symptoms, interacting as a 
confounding factor in this case. However, the results of the studies analyzed indicate the importance 
of taking into account the current scenario, which is worrying since it is known that the percentage of 
pregnant women who use these drugs is quite high. In the United States, for example, antidepressant 
medication reaches more than eight percent of pregnant women [34]. It is understood that depression 
reaches a large number of people and that women are especially affected by it [38]. Additionally, in 
this situation, the risks of untreated depression with medication during pregnancy are much greater 
than the adverse effects that the antidepressants can trigger. It is known, for example, that there are 
adverse perinatal outcomes, besides direct risks to the fetus [4], depending on the severity of the de-
pressive symptoms. However, medication is not the only option for treating depression. Since there 
are serious adverse effects that the use of antidepressants can cause in pregnant women, such as hy-
pertensive disorders, it is important to foster alternative treatments, for example, psychotherapy. For 
this reason, it is essential for the woman to be accompanied by a qualified professional team that can 
identify risk factors for mental health, such as depressive symptoms, even in a lighter intensity, given 
the complications that this disease can cause.
Another important risk factor for gestational hypertension cited in some of studies included in this 
review was the association not only with depression, but also with high BMI. Obesity and depression 
have been cited as the most prevalent comorbidities of gestation [29, 7]. Both are associated with 
complications of pregnancy, including gestational hypertension or preeclampsia, and can take the 
development of many pregnancy adverse outcomes [14]. Obesity is widely known as a risk factor for 
the development of hypertension [6, 26]. However, the correlation between higher BMI associated 
to depression and the development of gestational hypertension has not been fully established yet. 
Whereas some studies show that to be a little overweight is a risk factor for hypertensive disorders 
[8, 31]; others do not find this association [24]. We found two articles that studied the correlation 
between BMI, depression and gestational hypertension. Lutsiv O, et al. proved that being obese and 
depressed increases the prevalence of comorbidities during pregnancy, including gestational hyper-
tension and preeclampsia [14]. Winkel, et al. also showed a significant association between BMI 
and hypertensive disorders in pregnancy, which appears to be somewhat more relevant in relation to 
anxiety and depression [36]. 
CONCLUSIONS
This review demonstrates that, in general, depression is associated with hypertensive disorders 
in pregnancy. Women with more severe depressive symptoms have particularly higher risks of pre-
eclampsia. Antidepressant use and higher BMI also showed highs odd ratios, relating to hypertensive 
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disorders in pregnancy. However, there are important limitations in this review: the number of stud-
ies included was small, although samples were large. The age of women in the studies was different, 
although most were about thirty years old. Gestational age was different, too. Nevertheless, the third 
gestational trimester was the most studied. Additionally, the instruments and scales used to assess 
depression in women were different, making it difficult to compare them, despite everything was 
validated to the used language.
Considering this limitations, other studies are necessary based in scales more widely dissemi-
nated, as Beck Depression Inventory (BDI) or Diagnostic and Statistical Manual of Mental Disorders 
(DSM) for depression diagnosis, for example. Furthermore, it is clear that a more frequent follow-up 
of the pregnant women is fundamental not only in relation to physical but also psychological changes, 
since serious outcomes can occur in these cases.
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